230 related articles for article (PubMed ID: 21978260)
1. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
2. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
5. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
[TBL] [Abstract][Full Text] [Related]
6. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
[TBL] [Abstract][Full Text] [Related]
7. Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs.
Uusna J; Langel K; Langel Ü
Methods Mol Biol; 2015; 1324():133-48. PubMed ID: 26202267
[TBL] [Abstract][Full Text] [Related]
8. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies.
Song J; Kai M; Zhang W; Zhang J; Liu L; Zhang B; Liu X; Wang R
Peptides; 2011 Sep; 32(9):1934-41. PubMed ID: 21827806
[TBL] [Abstract][Full Text] [Related]
10. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
12. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
13. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
El-Andaloussi S; Järver P; Johansson HJ; Langel U
Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
[TBL] [Abstract][Full Text] [Related]
14. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
[TBL] [Abstract][Full Text] [Related]
16. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
17. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
18. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
